The present invention relates to the treatment of prostate cancer. Methods and compositions comprising recombinant BCG are provided for eliciting potent immune responses against prostate specific antigens that are effective for treatment of prostate cancer and metastatic disease.

 
Web www.patentalert.com

< Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain

< Live genetically attenuated malaria vaccine

> Extracts obtained from cell line cultures from plants belonging to the Oleaceae family (e.g. Syringa vulgaris), their preparation and use

> Tumor suppressor gene, p47ING3
~ 00609